Carelabs Co.,Ltd announced that it has received KRW 11 billion in funding from PSI International, Inc., NH Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm
March 14, 2021
Share
On March 15, 2021, Carelabs Co.,Ltd (KOSDAQ:A263700) closed the transaction.
Carelabs Co.,Ltd is a Korea-based company mainly engaged in the development and sale of software. Along with subsidiaries, the Company operates its business through three segments. The Healthcare Digital Marketing segment is involved in marketing planning, production and agency business. The Healthcare Media Platform segment is involved in the provision of hospital pharmacy search services and community apps related to beauty care. The products are sold under the name of GOODOC and BABITALK. The Healthcare Solution segment provides customer relationship management (CRM) software, prescription security systems, and pharmacy billing programs. The Company distributes its products within the domestic market and to overseas markets.
Carelabs Co.,Ltd announced that it has received KRW 11 billion in funding from PSI International, Inc., NH Investment & Securities Co., Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm